1. Home
  2. GEO vs HRMY Comparison

GEO vs HRMY Comparison

Compare GEO & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEO
  • HRMY
  • Stock Information
  • Founded
  • GEO 1984
  • HRMY 2017
  • Country
  • GEO United States
  • HRMY United States
  • Employees
  • GEO N/A
  • HRMY N/A
  • Industry
  • GEO Homebuilding
  • HRMY Biotechnology: Pharmaceutical Preparations
  • Sector
  • GEO Consumer Discretionary
  • HRMY Health Care
  • Exchange
  • GEO Nasdaq
  • HRMY Nasdaq
  • Market Cap
  • GEO 3.9B
  • HRMY 1.8B
  • IPO Year
  • GEO 1994
  • HRMY 2020
  • Fundamental
  • Price
  • GEO $26.07
  • HRMY $34.00
  • Analyst Decision
  • GEO Strong Buy
  • HRMY Strong Buy
  • Analyst Count
  • GEO 5
  • HRMY 9
  • Target Price
  • GEO $44.50
  • HRMY $54.44
  • AVG Volume (30 Days)
  • GEO 3.2M
  • HRMY 642.5K
  • Earning Date
  • GEO 08-06-2025
  • HRMY 08-05-2025
  • Dividend Yield
  • GEO N/A
  • HRMY N/A
  • EPS Growth
  • GEO N/A
  • HRMY 13.13
  • EPS
  • GEO 0.23
  • HRMY 2.62
  • Revenue
  • GEO $2,422,677,000.00
  • HRMY $744,852,000.00
  • Revenue This Year
  • GEO $8.72
  • HRMY $20.10
  • Revenue Next Year
  • GEO $27.89
  • HRMY $18.01
  • P/E Ratio
  • GEO $114.69
  • HRMY $13.10
  • Revenue Growth
  • GEO 0.50
  • HRMY 20.62
  • 52 Week Low
  • GEO $11.75
  • HRMY $26.47
  • 52 Week High
  • GEO $36.46
  • HRMY $41.61
  • Technical
  • Relative Strength Index (RSI)
  • GEO 54.90
  • HRMY 58.91
  • Support Level
  • GEO $25.31
  • HRMY $31.70
  • Resistance Level
  • GEO $26.63
  • HRMY $35.08
  • Average True Range (ATR)
  • GEO 0.94
  • HRMY 0.95
  • MACD
  • GEO 0.37
  • HRMY 0.27
  • Stochastic Oscillator
  • GEO 75.23
  • HRMY 71.80

About GEO Geo Group Inc (The) REIT

The GEO Group Inc specializes in detention facilities and community reentry centers. It operates in four segments: U.S. Secure Services, which mainly encompasses U.S.-based secure services business; Electronic Monitoring and Supervision Services, which conducts its services in the United States, represents services provided to adults for monitoring services and evidence-based supervision and treatment programs for community-based parolees, probationers, and pretrial defendants; Reentry Services conducts its services in the United States represents services provided to adults for residential and non-residential treatment, educational and community-based programs, pre-release and half-way house programs; and International Services.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: